Skip to Main Content

Disclaimer »
Advertising

Shopping Cart
shopAAP
Shopping Cart
Create Account
Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination
Share

FDA approves Dupixent for eosinophilic esophagitis; expands indication for atopic dermatitis

August 1, 2022
from the Food and Drug Administration
Article type: FDA Update
Topics:
Allergy/Immunology Dermatology Pharmacology
You do not currently have access to this content.
Don't already have an account? Register

Advertising Disclaimer »

Most Read

1. New flu guidance for 2023-’24 season emphasizes need to improve access to vaccination

2. CDC OKs maternal RSV vaccine, provides updated guidance for nirsevimab

3. COVID-19 hospital admissions among children rising again

4. Study of pediatric medical overuse includes routine practices, common surgeries

Read the latest issue

Subscribe to AAP News

Column collections

Topic collections

  • Online ISSN 1556-3332
  • Print ISSN 1073-0397

Journals

Policy

Books

News

Solutions

First 1,000 Days Knowledge Center


Institutions/Librarians

Group Practices

Licensing/Permissions

Integrations

Advertising

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept